Davide Volpi
Papers
1
Total Citations
18
H-Index
1
About
Davide Volpi is a pioneering surgical oncologist whose work sits at the intersection of molecular imaging and precision surgery. His primary research focuses on intraoperative fluorescence guidance for prostate cancer, leveraging prostate-specific membrane antigen (PSMA) as a molecular target. Volpi’s landmark contribution is the first-in-human study of the PSMA Minibody IR800-IAB2M, a humanised antibody fragment conjugated to a near-infrared fluorophore, designed to illuminate cancerous tissue in real time during robot-assisted laparoscopic radical prostatectomy. This 2024 study, already garnering 18 citations, demonstrated the feasibility of molecularly targeted fluorescence guidance, offering surgeons a new tool to achieve more complete resections while sparing healthy tissue. By translating a novel imaging agent from bench to bedside, Volpi has opened a new frontier in urologic oncology, where the boundary between diagnostic imaging and therapeutic intervention continues to blur. His work not only advances the field of image-guided surgery but also sets the stage for broader applications of targeted fluorescence in other solid tumours.
Research Focus
Key Achievements
Top Papers
- 1